244 related articles for article (PubMed ID: 33193737)
21. Development and External Validation of a Novel Immune Checkpoint-Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma.
Zhao E; Chen S; Dang Y
Front Mol Biosci; 2020; 7():620765. PubMed ID: 33553243
[No Abstract] [Full Text] [Related]
22. A Prognostic Model Based on RNA Binding Protein Predicts Clinical Outcomes in Hepatocellular Carcinoma Patients.
Man Z; Chen Y; Gao L; Xei G; Li Q; Lu Q; Yan J
Front Oncol; 2020; 10():613102. PubMed ID: 33643914
[TBL] [Abstract][Full Text] [Related]
23. A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma.
Liu J; Lu J; Li W
Stem Cells Int; 2021; 2021():5546032. PubMed ID: 34188686
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Karyopherin α2 in small cell carcinoma of the cervix correlates with poor prognosis.
Liao LM; Gu ZB; Fang M; Yao GJ; Huang L
Int J Clin Exp Pathol; 2022; 15(6):241-246. PubMed ID: 35795090
[TBL] [Abstract][Full Text] [Related]
25. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
[TBL] [Abstract][Full Text] [Related]
26. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
27. Combined signature of nine immune-related genes: a novel risk score for predicting prognosis in hepatocellular carcinoma.
Tang Y; Zeng Z; Wang J; Li G; Huang C; Dong X; Feng Z
Am J Transl Res; 2020; 12(4):1184-1202. PubMed ID: 32355535
[TBL] [Abstract][Full Text] [Related]
28. Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma.
Li W; Li X; Gao LN; You CG
Front Genet; 2020; 11():185. PubMed ID: 32194639
[TBL] [Abstract][Full Text] [Related]
29. ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma.
Liu F; Liang J; Long P; Zhu L; Hou W; Wu X; Luo C
Front Oncol; 2021; 11():799566. PubMed ID: 35071004
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma.
Wang WJ; Wang H; Hua TY; Song W; Zhu J; Wang JJ; Huang YQ; Ding ZL
Front Genet; 2020; 11():55. PubMed ID: 32158466
[TBL] [Abstract][Full Text] [Related]
31. Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Long S; Peng F; Song B; Wang L; Chen J; Shang B
Int J Gen Med; 2021; 14():5483-5492. PubMed ID: 34531676
[TBL] [Abstract][Full Text] [Related]
32. Screening and Verification of Key Ubiquitination Genes Related to Immune Infiltration in Stage III/IV Hepatocellular Carcinoma.
Tang Y; Cao J; Peng R; Mao X; Su B; Tang H; Tu D; Zhou J; Jiang G; Jin S; Wang Q; Zhang C; Liu R; Zhang C; Bai D
J Hepatocell Carcinoma; 2023; 10():765-781. PubMed ID: 37250505
[TBL] [Abstract][Full Text] [Related]
33. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic KPNA2 Serves as a Biomarker and Immune Infiltration in Patients With HPV Positive Tongue Squamous Cell Carcinoma.
Gao L; Li Y; Yu C; Liu DX; Wu KH; Wei ZL; Liu MY; Yu L
Front Oncol; 2022; 12():847793. PubMed ID: 35860570
[TBL] [Abstract][Full Text] [Related]
35. miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axis.
Liang C; Xu Y; Ge H; Xing B; Li G; Li G; Wu J
Oncotarget; 2017 Dec; 8(64):107543-107557. PubMed ID: 29296185
[TBL] [Abstract][Full Text] [Related]
36. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
37. PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration.
Liu X; Zhang Y; Wang Z; Liu L; Zhang G; Li J; Ren Z; Dong Z; Yu Z
J Hepatocell Carcinoma; 2021; 8():1495-1511. PubMed ID: 34881207
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Pathol Res Pract; 2019 May; 215(5):939-945. PubMed ID: 30723051
[TBL] [Abstract][Full Text] [Related]
40. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
Chen W; Tang D; Ou M; Dai Y
DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
